Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Issue: New safety information
Remove filter for
Issue: Product safety
Remove filter for
Last updated: August 2022
Remove filter for
Last updated: 2022
Remove filter for
Type: Health professional risk communication
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 1 of 1 items.
IMBRUVICA (ibrutinib) - Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac Failure
AlertHealth professional risk communication | 2022-08-29